Corporate Updates

Veeda Oncology announces USD 8.4 million in new business

Views: 696

eHealth BureauVeeda Oncology, a full service Oncology CRO with facilities in North America, Europe and India, has been awarded over USD 8.4 million of new clinical research programs. The awarded work will be conducted in India, Europe and the United States and will include services for monitoring, data management and biostatistics, medical monitoring, safety, site management and project management.Matt Bowman, President and CEO of Veeda Oncology, stated “We are enjoying our continued repeat business from our existing clients as well as these five new clients. The feedback from our clients is that they value our focused approach to oncology and our strong ution of programs, which is due to our team’s experience and expertise in oncology”.Veeda Oncology is a full service Oncology CRO with the unique capability of providing rapid and strong global oncology patient accrual with an effective cost structure in North America, Europe and India.Veeda Oncology is part of Veeda Group, the largest Phase I CRO in India also engaged in early clinical development and Phase IIa clinical research since 2005 having 6 offices across India, UK, USA & Europe. Veeda Clinical Research has been awarded as ‘Indian Clinical Organisation of the Year 2009’ by Frost & Sullivan.

Eletsonline News

Latest News

To Top